Neurofibrillary tau pathology modulated by genetic variation of α-synuclein

Annals of Neurology

Volumn 64, Issue 3, 2008, Pages 348-352

  Peuralinna, Terhi ^a   Oinas, Minna ^b   Polvikoski, Tuomo ^b,c   Paetau, Anders ^b   Sulkava, Raimo ^d   Niinistö, Leena ^e   Kalimo, Hannu ^b   Hernandez, Dena ^f   Hardy, John ^f,g   Singleton, Andrew ^f   Tienari, Pentti J ^a,b   Myllykangas, Liisa ^b,h  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e Katriina Geriatric Hospital   (Finland)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; TAU PROTEIN;

AGED; ARTICLE; AUTOPSY; BRAIN TISSUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GENETIC MARKER; GENETIC VARIABILITY; GERIATRIC PATIENT; HUMAN; HUMAN TISSUE; INTRON; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NERVE DEGENERATION; NEUROFILAMENT; NEUROMODULATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TAUOPATHY;

AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BRAIN; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; LEWY BODIES; MALE; NEOCORTEX; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; NEURONS; TAU PROTEINS; VARIATION (GENETICS);

EID: 54849410628     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21446     Document Type: Article

References (21)

1. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
2. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
3. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
4. Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
5. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164 -173.
6. Farrer M, Maraganore DM, Lockhart P, et al. Alpha-synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 2001;10:1847-1851.
7. Mueller JC, Fuchs J, Hofer A, et al. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol 2005;57:535-541.
8. Mizuta I, Satake W, Nakabayashi Y, et al. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Mol Genet 2006;15:1151-1158.
9. Martin ER, Scott WK, Nance MA, et al. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA 2001;286:2245-2250.
10. Goris A, Williams-Gray CH, Clark GR, et al. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol 2007;62:145-153.
11. Mamah CE, Lesnick TG, Lincoln SJ, et al. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. Ann Neurol 2005;57:439-443.
12. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
13. Polvikoski T, Sulkava R, Myllykangas L, et al. Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology 2001;56:1690 -1696.
14. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005;65:1863-1872.
15. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995;333:1242-1247.
16. Clarimon J, Gray RR, Williams LN, et al. Linkage disequilibrium and association analysis of alpha-synuclein and alcohol and drug dependence in two American indian populations. Alcohol Clin Exp Res 2007;31:546 -554.
17. Myllykangas L, Polvikoski T, Sulkava R, et al. Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population. Ann Neurol 1999;46:382-390.
18. Giasson BI, Forman MS, Higuchi M, et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003;300:636-640.
19. Galpern WR, Lang AE. Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 2006;59:449-458.
20. Eerola J, Hernandez D, Launes J, et al. Assessment of a DJ-1 (PARK7) polymorphism in Finnish Parkinson's disease. Neurology 2003;61:1000 -1002.
21. Zaccai J, Ince P, Brayne C. Population-based neuropathological studies of dementia: design, methods and areas of investigation - a systematic review. BMC Neurol 2006;6:2.